ADVI and American Cancer Society Cancer Action Network Discuss IRA Impacts

ADVI experts Lindsay Bealor Greenleaf, vice president and head of policy, and Brenna Raines, director of policy and reimbursement, joined the American Cancer Society Cancer Action Network’s webinar on September 26, titled, Rx Negotiation: The Potential Impact on Cancer Patients. In this webinar, the team discussed some of the key provisions of the Inflation Reduction Act (IRA) including Part D redesign, government negotiation, and the potential impact of the IRA on key stakeholders.

Listen in Here – ACS CAN Inflation Reduction Act Rx Negotiation: The Potential Impact on Cancer Patients Webinar

 

ADVI Team

Lindsay Bealor Greenleaf, JD, MBA

Solution Leader, Federal and State Policy

Brenna Raines

Senior Director

Further Resources:

ADVI insights

Insights,

| Lindsay Bealor Greenleaf, JD, MBA - Solution Leader, Federal and State Policy

ADVI Instant: CMS Releases 2025 Notice of Benefit and Payment Parameters Final Rule

Insights,

| Lindsay Bealor Greenleaf, JD, MBA - Solution Leader, Federal and State Policy

ADVI Instant: CY 2025 Policy and Technical Changes to the MA and Part D Final Rule Released

Insights,

| Lindsay Bealor Greenleaf, JD, MBA - Solution Leader, Federal and State Policy

ADVI Instant: CY 2025 MA/Part D Rate Announcement and Part D Redesign Instructions Released

Insights,

| Lindsay Bealor Greenleaf, JD, MBA - Solution Leader, Federal and State Policy

ADVI Instant: White House Releases President Biden’s FY 2025 Budget Request